CLAIM #33814 · Johnson & Johnson (JNJ) · 2023Q4 earnings call · Jan 23, 2024 · due Dec 31, 2024
“there's nothing that happened in Q4 that has us concerned about our outlook or calls around margin profile or EPS for the balance of this upcoming year.”
Joseph Wolk · CFO
PENDING
graded after results covering Dec 31, 2024 are reported
Verify independently
SEC filings for JNJ ↗ · Claim quote is verbatim from the 2023Q4 earnings call.